SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

High Roller Technologies, Inc. is an evolving and growth-oriented iCasino and entertainment company, which engages in the business of operating an online gaming business offering casino betting games to customers. The firm also offers a wide range of games including many that are available in land-based casinos, such as blackjack, roulette, baccarat, poker, and slot machines. The company was founded by Michael Alexander Cribari and Brandon Christopher Eachus on December 21, 2021 and is headquartered in Las Vegas, NV.

High Roller Technologies Inc.

High Roller Technologies Inc

High Roller Technologies (ROLR) is trending with extreme volatility following its exclusive partnership with crypto.com/us to launch event-based prediction markets in the United States, targeting a market with substantial growth potential. The trading community is actively discussing multiple halts and the possibility of a significant short squeeze, drawing parallels to previous parabolic stock movements.

Critical Metals Corp. engages in the mining, exploration, and development of lithium metals. It owns Wolfsberg Project and Tanbreez Project. The company was founded on October 24, 2022 and is headquartered in British Virgin Islands.

Critical Metals Corp.

Critical Metals Corp. (CRML) is trending amid intense anticipation surrounding high-level US discussions with Greenland and Denmark, focused on securing critical mineral rights and strategic geopolitical interests in the Arctic. The community is actively debating a potential short squeeze, fueled by recently announced high-grade rare earth drilling results from CRML's Tanbreez project and speculation on significant upside from any favorable strategic agreements.

Meta Platforms, Inc. engages in the development of social media applications. It builds technology that helps people connect and share, find communities, and grow businesses. It operates through the Family of Apps (FoA) and Reality Labs (RL) segments. The FoA segment consists of Facebook, Instagram, Messenger, WhatsApp, and other services. The RL segment includes augmented, mixed and virtual reality related consumer hardware, software, and content. The company was founded by Mark Elliot Zuckerberg, Dustin Moskovitz, Chris R. Hughes, Andrew McCollum, and Eduardo P. Saverin on February 4, 2004, and is headquartered in Menlo Park, CA.

Meta Platforms Inc - Ordinary Shares - Class A

Meta Platforms Inc

Meta Platforms is trending as it undergoes a significant strategic shift towards AI, announcing a massive "Meta Compute" infrastructure buildout and nuclear energy deals while reportedly cutting 10% of its Reality Labs division. The community is sharply divided, with some investors questioning the substantial AI spending and perceived lack of immediate returns, while others view these moves as crucial long-term investments positioning Meta for future growth and a potential stock rebound.

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

POET Technologies is trending amid intense community speculation on its crucial role in the rapidly evolving AI photonics sector, fueled by recent industry discussions around advanced optical networking platforms. Investors are navigating significant options activity and eagerly awaiting updates, as many highlight POET's patented Optical Interposer technology as a transformative solution for high-speed, energy-efficient data centers.

Strategy, Inc. engages in the provision of enterprise analytics and mobility software. The firm designs, develops, markets, and sells software platforms through licensing arrangements and cloud-based subscriptions and related services. Its product packages include Hyper. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Vienna, VA.

Strategy Inc. - Ordinary Shares - Class A

Strategy

MicroStrategy (MSTR) is a focal point of discussion as Bitcoin makes a notable push towards higher price levels, exciting bulls who see its market capitalization trading at a discount to its significant Bitcoin holdings and anticipate a potential short squeeze. However, skepticism persists among some investors who highlight ongoing share dilution through At-The-Market sales, questioning MSTR's ability to maintain pace with Bitcoin's rally.

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Viking Therapeutics Inc

Viking Therapeutics (VKTX) is trending at the J.P. Morgan Healthcare Conference, fueled by the publication of strong Phase 2 data for its obesity drug VK2735 and remarks from Novo Nordisk's CEO about significant M&A in the weight-loss sector. The community is highly focused on a potential major partnership or acquisition, anticipating FDA clarity on VK2735's oral formulation progressing directly to Phase 3, amidst ongoing debates about its "best-in-class" potential and market valuation. This positions VKTX as a key player in the rapidly expanding and competitive obesity treatment landscape.

Microsoft Corp. engages in the development and support of software, services, devices, and solutions. It operates through the following segments: Productivity and Business Processes, Intelligent Cloud, and More Personal Computing. The Productivity and Business Processes segment is composed of products and services relating to productivity, communication, and information services such as Office Commercial, Office Consumer, LinkedIn, and Dynamics business solutions. The Intelligent Cloud segment consists of public, private, and hybrid server products and cloud services for businesses and developers, as well as enterprise and partner services. The More Personal Computing segment refers to products and services including Windows operating system, Windows cloud services, Surface, HoloLens, personal computer accessories, Xbox hardware, Xbox Cloud Gaming, Microsoft News, and Microsoft Edge. The company was founded by Paul Gardner Allen and William Henry Gates, III in 1975 and is headquartered in Redmond, WA.

Microsoft Corporation

Microsoft Corp

Microsoft is actively trending amid discussions about increased capital expenditures for its AI data infrastructure, a concern amplified by recent governmental focus on tech companies covering the full cost of data center energy. While many traders are expressing bearish sentiment and actively shorting the stock, a significant portion of the community sees the current pullback as a compelling buying opportunity, emphasizing Microsoft's strong fundamentals and AI monetization strategy in a volatile mega-cap tech landscape. The ongoing debate centers on the balance between substantial AI investments and their eventual return on investment.

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflix is trending amid reports it may switch to an all-cash offer for Warner Bros. Discovery, a move seen by many as a strategic response to ongoing acquisition competition and an upcoming financial report. This potential shift sparks divided community discussion, with some viewing it as a bullish signal for avoiding share dilution and showcasing financial strength, while others express concern over the significant debt implication for the streaming giant.

Bitmine Immersion Technologies, Inc. is a technology company focused on acquiring, holding, and actively managing ETH as its primary treasury reserve asset. It prioritizes digital ecosystem services, such as consultancy and advisory works. The company was founded on August 16, 1995 and is headquartered in Las Vegas, NV.

BitMine Immersion Technologies Inc

Bitmine Immersion Technologies Inc

Bitmine Immersion Technologies is currently a major topic due to an upcoming shareholder vote on significantly increasing authorized shares, sparking intense debate among investors. Many express strong apprehension over potential dilution and the company's observed underperformance relative to Ethereum's recent upward movement, while others support the proposal as vital for strategic growth, future acquisitions, and scaling its Ethereum treasury. This pivotal decision is driving considerable uncertainty and discussion among shareholders as the voting deadline nears, amidst broader crypto market strength.

Alpha Tau Medical Ltd. is a clinical-stage oncology therapeutics company, which focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy for the treatment of cancer. The firm is involved in the clinical trials at cancer centers with indications that include skin cancer, oral cavity cancer, breast cancer, and pancreatic cancer. The company was founded by Uzi Sofer, Yona Keisari, and Itzhak Kelson in November 2015 and is headquartered in Jerusalem, Israel.

Alpha Tau Medical Ltd

ALPHA TAU MEDICAL LTD

Alpha Tau Medical is seeing strong community interest fueled by its pivotal presentation at the J.P. Morgan Healthcare Conference and widespread anticipation for Japan's PMDA approval of its Alpha DaRT skin cancer treatment. Investors are highly optimistic about the company's groundbreaking alpha radiation therapy, touting recent positive clinical data in pancreatic and glioblastoma cancer trials as key drivers for increasing institutional attention in the rapidly evolving oncology sector.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$NVAX  Based on the news and data provided on deliveries and EU, Australia, NZ price leak,  seems like Novavax hit the $1 Billion sales/revenue for Q1.  If  there&#39;s 1 batch of 3.2 million doses for Canada and the UK this week, that moves revenue to around 1.15 Billion. Novavax also gets around $200M every quarter in 2021 for grants/royalties.  1st Quarter gross sales could be $1B - $1.3B in the May 9 Q1 report.

Paul Di

e0fknu2k

Ramón de la Vega

Delicious_Aloysius

Tim Chron

Jacked to the twits!

Jerry

Scoop

Moixet

Charging Bull

David G

Louie Gi

Alan

Truth Will Set You Free

Muskington

DarvasBoxing

William L Maltby

Twix

TopShelfStock

Wade

Jose David

Tony Wadie

Skiwp

Álvaro González

Armin Yukihura

Kevin Chan

Alex Johnson

John

Stian Bøhlerengen

Moyses Garcia

StockTwits Web

Novavax Inc

  Based on the news and data provided on deliveries and EU, Australia, NZ price leak,  seems like Novavax hit the $1 Billion sales/revenue for Q1.  If  there's 1 batch of 3.2 million doses for Canada and the UK this week, that moves revenue to around 1.15 Billion. Novavax also gets around $200M every quarter in 2021 for grants/royalties.  1st Quarter gross sales could be $1B - $1.3B in the May 9 Q1 report.

Al Y

@ay8888 thats a very optimistic price per dose because we don&#39;t know how much they are even paying SII for the doses

Keegan

Jo Wu

 thats a very optimistic price per dose because we don't know how much they are even paying SII for the doses

Diego Raul Gonzales Jr. III

@ay8888 Seems reasonable given the guidance NVAX provided that Q1 would approach or even surpass $1B in revenue.  The CFO commentary on COGS being incurred in Q4 bodes well that margins could benefit in Q1/Q2.  So does $1+B revenue finally translate to the 3x or more SP to Revenue that MRNA is showing

 Seems reasonable given the guidance NVAX provided that Q1 would approach or even surpass $1B in revenue.  The CFO commentary on COGS being incurred in Q4 bodes well that margins could benefit in Q1/Q2.  So does $1+B revenue finally translate to the 3x or more SP to Revenue that MRNA is showing

Aehr Test Systems

Arena Group Holdings Inc (The)

@ay8888 This company has not been transparent with us! The doses produced and doses shipped are just totally do not make any sense. IR will not answer my questions.

StatManDan

 This company has not been transparent with us! The doses produced and doses shipped are just totally do not make any sense. IR will not answer my questions.

Pfizer Inc

Beyond Meat Inc

AST SpaceMobile Inc

MicroCloud Hologram Inc

@ay8888 i didnt know  about  the 19.2M to india

StockTwits For Android 

Palantir Technologies Inc

Affirm Holdings Inc

Upstart Holdings Inc

DLocal Limited

Pagaya Technologies Ltd

Klarna Group plc

Bilvo

$nvax This revenue is in line with analysts target for 4-5 Bilion revenue for 2022, an at this revenue level - analysts are estimating around $200 per share.  EU and Australia/NZ were revealed in the news at $20.90 and $24. Novavax receives grants and royalties every quarter at around $200 million . Some companies use Matrix M for their products.

Paul

Brian Isaacson

StockTwits for iOS

 This revenue is in line with analysts target for 4-5 Bilion revenue for 2022, an at this revenue level - analysts are estimating around $200 per share.  EU and Australia/NZ were revealed in the news at $20.90 and $24. Novavax receives grants and royalties every quarter at around $200 million . Some companies use Matrix M for their products.

@ay8888 Look really accurate...... we need more countries to immediately approve us for booster, get 12-17 age group authorized for more shots, and approvals from Japan, USA, Israel, and S Africa.. 
 
I think we will do at least $2B in Q3 and Q4.    And should do $1.5 to $2B in Q2.....  It&#39;s possible we could do $6.5 to $7.5B if USA gets going on 110 million and approves booster faster for additional orders. 
 
Also, could get more orders now from India and end of year boosters for China.....booster.

 Look really accurate...... we need more countries to immediately approve us for booster, get 12-17 age group authorized for more shots, and approvals from Japan, USA, Israel, and S Africa.. 
 
I think we will do at least $2B in Q3 and Q4.    And should do $1.5 to $2B in Q2.....  It's possible we could do $6.5 to $7.5B if USA gets going on 110 million and approves booster faster for additional orders. 
 
Also, could get more orders now from India and end of year boosters for China.....booster.

XPeng Inc - ADR

@Bilvo  this was Jan. 2022 .. India cleared it for their use 
https://www.moneycontrol.com/news/trends/health-trends/about-1-crore-doses-of-siis-covovax-cleared-by-govt-lab-for-public-use-testing-of-bio-es-corbevax-to-begin-7902671.html

Nearly one crore doses of the newly approved Covid-19 vaccine, Covovax, have been dispatched after the final round of quality and safety checks at the Central Drugs Laboratory (CDL), News18.com has learnt. Expanding India's vaccine basket, the Drugs Controller General of India (DCGI) on December 28 had approved the Serum Institute's Covovax and Biological E's Corbevax.

Moneycontrol

About 1 crore doses of SII's Covovax cleared by govt lab for public use, testing of Bio E's Corbevax to begin

  this was Jan. 2022 .. India cleared it for their use 


@ay8888 Not so loud there.  Someone might take it wrong and begin a buying spree with some serious buying.  That&#39;s what it&#39;ll take now that most of the retail traders have lost interest.  I think we have to wait for institutional traders to begin adding to positions.  I&#39;m not sure what they are waiting on.  But sales do look good, but with unfortunately deliveries are more concerning right now.  They have to complete orders.  If I were Vanguard or Blackrock, that what&#39;s I&#39;d be watching.

 Not so loud there.  Someone might take it wrong and begin a buying spree with some serious buying.  That's what it'll take now that most of the retail traders have lost interest.  I think we have to wait for institutional traders to begin adding to positions.  I'm not sure what they are waiting on.  But sales do look good, but with unfortunately deliveries are more concerning right now.  They have to complete orders.  If I were Vanguard or Blackrock, that what's I'd be watching.

Wolfspeed Inc

First Solar Inc

Moderna Inc

Advanced Micro Devices Inc

MP Materials Corporation

Ucore Rare Metals Inc.

Renesas Electronics Corp

George Snodgrass

@ay8888 I hope so and some more surprises for Q1. If Serum keeps there pledge/recommitment Starting in April 1 we should have a great year with or without USFDA!

 I hope so and some more surprises for Q1. If Serum keeps there pledge/recommitment Starting in April 1 we should have a great year with or without USFDA!